Repros Therapeutics submits Androxal revised indication statement to the FDA
Posted by: SomaNews on: 09 Feb, 2010
Repros Therapeutics submits Androxal revised indication statement to the FDA
Repros Therapeutics Inc. today announced that the Company, as requested by the FDA during the Type C meeting held on January 25, 2010, has sent a revised indication statement to the FDA’s Division of Reproductive and Urologic Products for the use of Androxal® in the treatment of men wishing to preserve fertility while being treated for their hypogonadal state.
| Buy Soma from Canadian Pharmacy Do not Wait any more! Order Generic Soma Medications! Free Prescription Online Online-Canadian-Pharmacies.org |
Canadian Pharmacy Painkillers: Hydrocodone, Oxycodone, Vicodin ES, Ambien, Xanax, Phentermine! Secure Shopping, Worldwide Shipping! www.CanadianPharmacyltd.net |
Related posts:
- Repros Therapeutics receives positive feedback from FDA for Androxal
- Repros Therapeutics requests Type B Meeting to review Androxal Phase III protocols
- Repros receives US patent for Androxal
Buy the Painkiller drugs from Canadian Pharmacy free prescription online. Hydrocodone is a semi-synthetic opioid similar in effects to morphine. Vicodin is hydrocodone mixed with acetaminophen. Oxycodone is used as an analgesic and is formulated into numerous pharmaceuticals including OxyContin (a controlled-release product) and with aspirin (Percodan) or with acetaminophen (Percoset).
Recent Comments